Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOXAG: Adjuvant Trastuzumab + Chemoradiotherapy in Gastric Cancer
NCT01748773Phase 2Completed
- Sponsor
- Roche
- Start
- Jan 2013
- Primary completion
- Aug 2015
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab in gastric cancer (GC), gastroesophageal junction cancer, sponsored by Roche. Started Jan 2013; status: completed.
02
Drugs
03
Conditions
gastric cancer (GC)gastroesophageal junction cancer
Beyond the preview
Go deeper on NCT01748773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01748773.